CA SB 1089
enactedPreventive Treatment Health Care Act.
California · 2025-2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did CA SB 1089 pass?
Yes. CA SB 1089 has been enacted into law. Latest recorded action (2026-09-28): Chaptered by Secretary of State. Chapter 725, Statutes of 2026.
What is CA SB 1089 about?
Existing law requires the California Health and Human Services Agency (CHHSA) to enter into partnerships resulting in the production of generic prescription drugs, including at least one form of insulin made available at production and dispensing costs, if one does not already exist in the market. Existing law additionally authorizes CHHSA to enter into partnerships to increase competition, lower prices, and address supply shortages for generic or brand name drugs to address emerging health concerns. This bill, the Preventive Treatment Health Care Act, would authorize CHHSA to enter into partnerships, if needed and subject to an appropriation, to increase competition, lower prices, and address supply shortages for at least one glucagon-like peptide-1 (GLP-1) antiobesity medication approved by the United States Food and Drug Administration (FDA) . The bill would require CHHSA to establish distribution partners, if needed, and make its best effort to negotiate pricing at or lower than the cost to Medi-Cal beneficiaries in 2025.
Who sponsors CA SB 1089?
Richardson is the primary sponsor of CA SB 1089, joined by 1 cosponsor.
Description
Existing law requires the California Health and Human Services Agency (CHHSA) to enter into partnerships resulting in the production of generic prescription drugs, including at least one form of insulin made available at production and dispensing costs, if one does not already exist in the market. Existing law additionally authorizes CHHSA to enter into partnerships to increase competition, lower prices, and address supply shortages for generic or brand name drugs to address emerging health concerns. This bill, the Preventive Treatment Health Care Act, would authorize CHHSA to enter into partnerships, if needed and subject to an appropriation, to increase competition, lower prices, and address supply shortages for at least one glucagon-like peptide-1 (GLP-1) antiobesity medication approved by the United States Food and Drug Administration (FDA) . The bill would require CHHSA to establish distribution partners, if needed, and make its best effort to negotiate pricing at or lower than the cost to Medi-Cal beneficiaries in 2025.
- Introduced
- 2026-02-13
- Latest action
- 2026-09-28 — Chaptered by Secretary of State. Chapter 725, Statutes of 2026.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Richardsonauthor
- Calozacoauthor
Committees
Not provided by source.
Action timeline
Newest first
2026-09-28
Chaptered by Secretary of State. Chapter 725, Statutes of 2026.
became-law
2026-09-28
Approved by the Governor.
executive-signature
2026-09-03
Enrolled and presented to the Governor at 3 p.m.
executive-receipt
2026-08-27
Assembly amendments concurred in. (Ayes 39. Noes 0.) Ordered to engrossing and enrolling.
2026-08-26
Ordered to special consent calendar.
2026-08-24
Read third time. Passed. Ordered to the Senate.
passage,reading-1,reading-3
2026-08-24
In Senate. Concurrence in Assembly amendments pending.
2026-08-24
Read third time. Passed. (Ayes 77. Noes 0. Page 6418.) Ordered to the Senate.
passage,reading-1,reading-3
2026-08-20
Read third time and amended.
amendment-passage,reading-1,reading-3
2026-08-20
Ordered to third reading.
reading-1,reading-3
2026-08-13
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2026-08-13
From committee: Do pass. (Ayes 14. Noes 0.) (August 13).
committee-passage,committee-passage-favorable
2026-08-13
Assembly Rule 63 suspended.
2026-08-05
August 5 set for first hearing. Placed on suspense file.
2026-06-22
Re-referred to Com. on APPR. pursuant to Assembly Rule 96.
referral-committee
2026-06-18
Read second time and amended. Re-referred to Com. on P. E. & R.
amendment-passage,reading-1,reading-2,referral-committee
2026-06-17
From committee: Do pass as amended and re-refer to Com. on P. E. & R. (Ayes 15. Noes 0.) (June 16).
amendment-passage,committee-passage,committee-passage-favorable,referral-committee
2026-06-04
Referred to Coms. on HEALTH and P. E. & R.
referral-committee
2026-05-27
In Assembly. Read first time. Held at Desk.
reading-1
2026-05-27
Read third time. Passed. (Ayes 39. Noes 0. Page 4499.) Ordered to the Assembly.
passage,reading-1,reading-3
2026-05-18
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2026-05-14
From committee: Do pass as amended. (Ayes 7. Noes 0. Page 4264.) (May 14).
amendment-passage,committee-passage,committee-passage-favorable
2026-05-14
Read second time and amended. Ordered to second reading.
amendment-passage,reading-1,reading-2
2026-05-08
Set for hearing May 14.
2026-05-04
May 4 hearing: Placed on APPR. suspense file.
2026-04-28
Set for hearing May 4.
2026-04-23
Read second time and amended. Re-referred to Com. on APPR.
amendment-passage,reading-1,reading-2,referral-committee
2026-04-22
From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 5. Noes 0. Page 4013.) (April 22).
amendment-passage,committee-passage,committee-passage-favorable,referral-committee
2026-04-16
From committee: Do pass and re-refer to Com. on L., P.E. & R. (Ayes 10. Noes 0. Page 3901.) (April 15). Re-referred to Com. on L., P.E. & R.
committee-passage,committee-passage-favorable,referral-committee
2026-04-15
Set for hearing April 22 in L., P.E. & R. pending receipt.
2026-03-27
Set for hearing April 15.
2026-03-24
From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2026-02-26
Referred to Coms. on HEALTH and L., P.E. & R.
referral-committee
2026-02-17
From printer. May be acted upon on or after March 16.
2026-02-13
Introduced. Read first time. To Com. on RLS. for assignment. To print.
introduction,reading-1,referral-committee
Versions
- 02/13/26 - Introduced — 2026-02-13Compare
- 03/24/26 - Amended Senate — 2026-03-24Compare
- 04/23/26 - Amended Senate — 2026-04-23Compare
- 05/14/26 - Amended Senate — 2026-05-14Compare
- 06/18/26 - Amended Assembly — 2026-06-18Compare
- 08/20/26 - Amended Assembly — 2026-08-20Compare
- 08/30/26 - Enrolled — 2026-08-30Compare
- 09/28/26 - Chaptered — 2026-09-28Compare
- (document, no version)Compare
- SB1089Compare
Documents
- application/pdf
- application/pdf
- application/pdf
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf
- application/pdf
- application/pdf
Votes
Do pass, but first be re-referred to the Committee on [Labor, Public Employment and Retirement ]
2026-04-15 · pass · 10-0
Member-level votes (11)
- Caballero: yes
- Menjivar: yes
- Durazo: yes
- Padilla: yes
- Valladares: yes
- Weber Pierson: yes
- Smallwood-Cuevas: yes
- Gonzalez: yes
- Grove: yes
- Rubio: yes
- Pérez: other
Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations]
2026-04-22 · pass · 5-0
Member-level votes (5)
- Durazo: yes
- Laird: yes
- Strickland: yes
- Cortese: yes
- Smallwood-Cuevas: yes
Placed on suspense file
2026-05-04 · pass · 7-0
Member-level votes (7)
- Dahle: yes
- Cervantes: yes
- Wahab: yes
- Richardson: yes
- Seyarto: yes
- Cabaldon: yes
- Grayson: yes
Do pass as amended
2026-05-14 · pass · 7-0
Member-level votes (7)
- Cervantes: yes
- Seyarto: yes
- Wahab: yes
- Cabaldon: yes
- Dahle: yes
- Richardson: yes
- Grayson: yes
3rd Reading
2026-05-27 · pass · 39-0
Member-level votes (40)
- Grayson: yes
- Ochoa Bogh: yes
- Hurtado: yes
- Strickland: yes
- Limón: yes
- Wahab: yes
- Cortese: yes
- Blakespear: yes
- Cervantes: yes
- Durazo: yes
- Smallwood-Cuevas: yes
- Reyes: yes
- Valladares: yes
- Cabaldon: yes
- Wiener: yes
- Alvarado-Gil: yes
- Padilla: yes
- Stern: yes
- Caballero: yes
- Niello: yes
- Umberg: yes
- Archuleta: yes
- Gonzalez: yes
- McGuire: yes
- Pérez: yes
- McNerney: yes
- Becker: yes
- Jones: yes
- Weber Pierson: yes
- Richardson: yes
- Arreguín: yes
- Ashby: yes
- Laird: yes
- Choi: yes
- Grove: yes
- Menjivar: yes
- Seyarto: yes
- Rubio: yes
- Allen: yes
- Dahle: other
Do pass as amended and be re-referred to the Committee on [Public Employment and Retirement]
2026-06-16 · pass · 15-0
Member-level votes (16)
- Patel: yes
- Aguiar-Curry: yes
- Bonta: yes
- Carrillo: yes
- Patterson: yes
- Sharp-Collins: yes
- Addis: yes
- Schiavo: yes
- Caloza: yes
- Ahrens: yes
- Celeste Rodriguez: yes
- Stefani: yes
- Mark González: yes
- Chen: yes
- Sanchez: yes
- Johnson: other
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-10-01T08:26:01.625218Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=SB 1089. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.